Bio-Techne Corp (TECH)
71.28
+0.23
(+0.32%)
USD |
NASDAQ |
Nov 22, 16:00
71.28
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Total Liabilities (Quarterly): 597.37M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 597.37M |
| June 30, 2024 | 635.02M |
| March 31, 2024 | 706.80M |
| December 31, 2023 | 767.19M |
| September 30, 2023 | 757.61M |
| June 30, 2023 | 672.18M |
| March 31, 2023 | 710.01M |
| December 31, 2022 | 536.30M |
| September 30, 2022 | 599.57M |
| June 30, 2022 | 593.79M |
| March 31, 2022 | 586.57M |
| December 31, 2021 | 602.32M |
| September 30, 2021 | 623.23M |
| June 30, 2021 | 691.72M |
| March 31, 2021 | 536.70M |
| December 31, 2020 | 537.01M |
| September 30, 2020 | 613.81M |
| June 30, 2020 | 646.40M |
| March 31, 2020 | 707.75M |
| December 31, 2019 | 675.07M |
| September 30, 2019 | 750.80M |
| June 30, 2019 | 718.82M |
| March 31, 2019 | 726.35M |
| December 31, 2018 | 748.41M |
| September 30, 2018 | 762.73M |
| Date | Value |
|---|---|
| June 30, 2018 | 514.14M |
| March 31, 2018 | 559.52M |
| December 31, 2017 | 557.60M |
| September 30, 2017 | 567.57M |
| June 30, 2017 | 608.59M |
| March 31, 2017 | 625.51M |
| December 31, 2016 | 629.45M |
| September 30, 2016 | 622.08M |
| June 30, 2016 | 250.30M |
| March 31, 2016 | 268.96M |
| December 31, 2015 | 277.11M |
| September 30, 2015 | 290.37M |
| June 30, 2015 | 216.42M |
| March 31, 2015 | 284.24M |
| December 31, 2014 | 298.32M |
| September 30, 2014 | 224.85M |
| June 30, 2014 | 67.23M |
| March 31, 2014 | 53.52M |
| December 31, 2013 | 53.64M |
| September 30, 2013 | 52.53M |
| June 30, 2013 | 40.56M |
| March 31, 2013 | 40.78M |
| December 31, 2012 | 30.00M |
| September 30, 2012 | 32.02M |
| June 30, 2012 | 44.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
536.30M
Minimum
Dec 2022
767.19M
Maximum
Dec 2023
639.82M
Average
629.12M
Median
Total Liabilities (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 3.116B |
| Boston Scientific Corp | 17.12B |
| ResMed Inc | 2.027B |
| Zimmer Biomet Holdings Inc | 9.337B |
| AIM ImmunoTech Inc | 10.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.736B |
| Shareholders Equity (Quarterly) | 2.139B |
| Debt to Equity Ratio | 0.1403 |
| Current Ratio | 4.563 |
| Net Debt Paydown Yield | 0.08% |